Published monthly, the journal CHEST® features peer-reviewed, cutting-edge original research in chest medicine: Pulmonary, critical care and sleep medicine and related disciplines. Journal topics include asthma, chest infections, COPD, critical care, diffuse lung disease, education and clinical practice, pulmonary vascular disease, sleep, thoracic oncology and the humanities.
Credit: Geoffrey Chupp, MD, et al. CHEST March 2022
Published monthly, the journal CHEST® features peer-reviewed, cutting-edge original research in chest medicine: Pulmonary, critical care and sleep medicine and related disciplines. Journal topics include asthma, chest infections, COPD, critical care, diffuse lung disease, education and clinical practice, pulmonary vascular disease, sleep, thoracic oncology and the humanities.
The March issue of CHEST journal contains 52 articles, including clinically relevant research, reviews, case series, commentary and more. Each month, the journal also offers complementary web and multimedia activities, including visual abstracts, to expand the reach of its most interesting, timely and relevant research.
“Nontuberculous mycobacterial pulmonary disease, a chronic infectious lung disease affecting tens of thousands of people every year, is the focus of one of [the journal] CHEST‘s newest special series,” says Editor in Chief of the journal, Peter Mazzone, MD, MPH, FCCP. “The latest piece from the series, ‘Nontuberculous Mycobacterial Pulmonary Disease: Clinical Epidemiologic Features, Risk Factors, and Diagnosis,’ can be found in the March issue.”
Also included in the current issue of the journal CHEST:
- Asthma
An observational study in 227 subjects with a 5-year follow-up, “ Bronchial Thermoplasty in Patients With Severe Asthma at 5 Years,” indicates bronchial thermoplasty may be a valuable add-on therapy for the treatment of subjects with severe asthma, including those on oral corticosteroids and omalizumab. A visual abstract for this research can be viewed here. - Critical Care
A systematic review, “The Cost of ARDS,” finds wide variations in costs reported because of differences in populations studied, costing methodology and health systems. A visual abstract for this research can be viewed here.
- Diffuse Lung Disease
Original research, “Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis and COPD,” demonstrates significant real-world improvements in exercise capacity, dyspnea and health-related quality of life in a cohort of patients with idiopathic pulmonary fibrosis participating in pulmonary rehabilitation. A visual abstract for this research can be viewed here. An animation of the research can be viewed here.
- Education and Clinical Practice
Looking at abdominal expiratory muscle fatty infiltration, “Characterizing Expiratory Respiratory Muscle Degeneration in Duchenne Muscular Dystrophy Using MRI” helped identify that airway clearance can become impaired when the internal and external oblique muscles reach about 50% replacement by fat. A visual abstract for this research can be viewed here.
To view the entire March issue of the CHEST journal, visit journal.chestnet.org, and follow @journal_CHEST on Twitter for the latest journal news.
About the American College of Chest Physicians
The American College of Chest Physicians® (CHEST) is the global leader in the prevention, diagnosis and treatment of chest diseases. Its mission is to champion advanced clinical practice, education, communication and research in chest medicine. It serves as an essential connection to clinical knowledge and resources for its 19,000+ members from around the world who provide patient care in pulmonary, critical care and sleep medicine. For information about the American College of Chest Physicians, and its flagship journal CHEST®, visit chestnet.org.
Journal
CHEST Journal
